Palomino Laboratories (PALX) Enterprise Value (2022 - 2025)
Palomino Laboratories (PALX) posted Enterprise Value of -$8.1 million for Q4 2025, down 2.85% sequentially from -$7.9 million in Q3 2025, and down 5931.21% YoY from $139275.5 in Q4 2024.
Palomino Laboratories (PALX) Enterprise Value (2022 - 2025) Analysis & Trends
Palomino Laboratories has reported Enterprise Value for 4 years, with the latest figure at -$8.1 million in Q4 2025.
- Quarterly Enterprise Value fell 5931.21% year-over-year to -$8.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8.1 million (down 5931.21% YoY) and the FY2025 annual result came in at -$8.1 million, down 5931.21% from the prior year.
- Enterprise Value fell to -$8.1 million in Q4 2025 per PALX's latest filing, from -$7.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$322.0 in Q2 2024 and troughed at -$8.1 million in Q4 2025.
- A 4-year average of -$1.5 million and a median of -$500.0 in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value rose 24.0% in 2023, then slumped 2452250.62% in 2025.
- Over 4 years, Enterprise Value stood at -$500.0 in 2022, then grew by 24.0% to -$380.0 in 2023, then tumbled by 35336.05% to -$134657.0 in 2024, then sank by 5931.21% to -$8.1 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$8.1 million, -$7.9 million, and -$1887.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.12 Mn |
| Sep 30, 2025 | -7.90 Mn |
| Jun 30, 2025 | -1,887.00 |
| Mar 31, 2025 | -18,220.00 |
| Dec 31, 2024 | -134,657.00 |
| Sep 30, 2024 | -322.00 |
| Jun 30, 2024 | -322.00 |
| Mar 31, 2024 | -380.00 |
| Dec 31, 2023 | -380.00 |
| Sep 30, 2023 | -380.00 |
| Dec 31, 2022 | -500.00 |